文献速递系统性红斑狼疮

美国风湿病学会儿童起病系统性红斑狼疮全局发作暂定标准

American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-04-25

该研究纳入268名有儿童起病系统性红斑狼疮诊治经验的儿科医生对患者档案进行评分,验证了基于SLEDAI或BILAG、医生整体评估、蛋白/肌酐比值和血沉变化的暂定发作标准,两种算法AUC均>0.93,并确定了轻度、中度、重度发作的阈值分数。

要点

  • 基于SLEDAI的标准:0.5×ΔSLEDAI+0.45×ΔPCR+0.5×ΔMD-global+0.02×ΔESR,发作分数≥6.4/3.0/0.6分别定为重度/中度/轻度发作。
  • 基于BILAG的标准:0.4×ΔBILAG+0.65×ΔPCR+0.5×ΔMD-global+0.02×ΔESR,发作分数≥7.4/3.7/2.2分别定为重度/中度/轻度发作。
  • 两种标准阈值对发作严重程度的敏感度和特异度均>82%。

核心结论

  • 儿童起病系统性红斑狼疮的暂定全局发作标准可用于识别经历发作的患者,并可区分发作的严重程度。

研究设计与样本

  • 验证性研究,纳入268名有儿童起病系统性红斑狼疮诊治经验的儿科医生对独特患者档案进行评分。
  • 以评分者对儿童起病系统性红斑狼疮病程(基线 vs 随访)的判读为金标准,检验暂定发作标准的敏感度、特异度和AUC。
  • 召开国际共识会议,按美国风湿病学会推荐对暂定发作标准进行排序,并界定轻度、中度、重度发作的阈值分数。

主要发现

  • 考虑SLEDAI或BILAG绝对变化(Δ)、MD-global、PCR和ESR的两种排名最高的候选标准准确性得到确认,AUC均>0.93。
  • 基于SLEDAI的标准(0.5×ΔSLEDAI+0.45×ΔPCR+0.5×ΔMD-global+0.02×ΔESR)发作分数≥6.4/3.0/0.6分别构成重度/中度/轻度发作。
  • 基于BILAG的算法(0.4×ΔBILAG+0.65×ΔPCR+0.5×ΔMD-global+0.02×ΔESR)发作分数≥7.4/3.7/2.2分别界定重度/中度/轻度发作。
  • 上述阈值(SLEDAI、BILAG)对捕获发作严重程度的敏感度和特异度均>82%。

关键数值与推荐

  • SLEDAI数值评分:A=12,B=8,C=1,D/E=0;BILAG数值评分:A=12,B=8,C=1,D/E=0。
  • 基于SLEDAI的发作分数≥6.4为重度发作、≥3.0为中度发作、≥0.6为轻度发作。
  • 基于BILAG的发作分数≥7.4为重度发作、≥3.7为中度发作、≥2.2为轻度发作。
  • 两种标准阈值对发作严重程度的敏感度和特异度均>82%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To validate the preliminary criteria of global flare for childhood-onset SLE (cSLE). METHODS: Pediatricians experienced in cSLE care (n = 268) rated unique patient profiles; results of standard cSLE laboratory testing and information about the cSLE flare descriptors were presented as follows: global assessment of patient well-being, physician global assessment of disease activity (MD-global), Disease Activity Index score, protein/creatinine ratio (PCR), and erythrocyte sedimentation rate (ESR). Using rater interpretation of the course of cSLE (baseline versus followup as the gold standard), performance (sensitivity, specificity, area under the receiver operating characteristic curve [AUC]) of the preliminary flare criteria was tested. An international consensus conference was held to rank the preliminary flare criteria as per the American College of Rheumatology recommendations and delineate threshold scores for minor, moderate, and major flares. RESULTS: The accuracy of the 2 highest-ranked candidate criteria that consider absolute changes (∆) of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or British Isles Lupus Assessment Group (BILAG) (numeric scoring: A = 12, B = 8, C = 1, and D/E = 0), MD-global, PCR, and ESR were confirmed (both AUC >0.93). For the SLEDAI-based criteria (0.5 × ∆SLEDAI + 0.45 × ∆PCR + 0.5 × ∆MD-global + 0.02 × ∆ESR) flare scores ≥6.4/3.0/0.6 constituted major/moderate/minor flares, respectively. For the BILAG-based algorithm (0.4 × ∆BILAG + 0.65 × ∆PCR + 0.5 × ∆MD-global + 0.02 × ∆ESR) flare scores ≥7.4/3.7/2.2 delineated major/moderator/minor flares, respectively. These threshold values (SLEDAI, BILAG) were all >82% sensitive and specific for capturing flare severity. CONCLUSION: Provisional criteria for global flares in cSLE are available to identify patients who experienced a flare. These criteria also allow for discrimination of the severity of cSLE exacerbations.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Brunner HI, Holland M, Beresford MW, et al. American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018. PMID: 29693328. doi:10.1002/acr.23557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。